BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32775427)

  • 1. Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
    Liu T; Zhang M; Sun D
    Biomed Res Int; 2020; 2020():5019746. PubMed ID: 32775427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma.
    Jiang Z; Wang J; Dao C; Zhu M; Li Y; Liu F; Zhao Y; Li J; Yang Y; Pan Z
    Apoptosis; 2024 Jun; 29(5-6):681-692. PubMed ID: 38281281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy.
    Bai D; Feng H; Yang J; Yin A; Qian A; Sugiyama H
    Cancer Sci; 2021 Jun; 112(6):2126-2139. PubMed ID: 33735492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics and immunogenomics analysis revealed PFKFB3 as a targetable hallmark and mediates sunitinib resistance in papillary renal cell carcinoma: in silico study with laboratory verification.
    Lu Z; Pan Y; Wang S; Wu J; Miao C; Wang Z
    Eur J Med Res; 2024 Apr; 29(1):236. PubMed ID: 38622715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma.
    Wang Q; Zhang Y; Zhang B; Fu Y; Zhao X; Zhang J; Zuo K; Xing Y; Jiang S; Qin Z; Li E; Guo H; Liu Z; Yang J
    Nat Commun; 2022 Jan; 13(1):31. PubMed ID: 35013217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors.
    Wang T; Lu R; Kapur P; Jaiswal BS; Hannan R; Zhang Z; Pedrosa I; Luke JJ; Zhang H; Goldstein LD; Yousuf Q; Gu YF; McKenzie T; Joyce A; Kim MS; Wang X; Luo D; Onabolu O; Stevens C; Xie Z; Chen M; Filatenkov A; Torrealba J; Luo X; Guo W; He J; Stawiski E; Modrusan Z; Durinck S; Seshagiri S; Brugarolas J
    Cancer Discov; 2018 Sep; 8(9):1142-1155. PubMed ID: 29884728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a mutation-related model in papillary renal cell carcinoma and associated immune infiltration.
    Li X; Liu Y; Zhou L; Wang J; Yang X
    Kidney Blood Press Res; 2024 May; ():. PubMed ID: 38714185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the tumor microenvironment in rare renal cancer histological types.
    Synnott NC; Poeta ML; Costantini M; Pfeiffer RM; Li M; Golubeva Y; Lawrence S; Mutreja K; Amoreo C; Dabrowska M; Simone G; Pescarmona E; Lenz P; Olanich M; Duggan M; Abubakar M; Fazio VM; Gallucci M; Sentinelli S; Landi MT
    J Pathol Clin Res; 2022 Jan; 8(1):88-98. PubMed ID: 34618413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches.
    Li C; Xiao Y; Kong J; Lai C; Chen Z; Li Z; Xie W
    Cell Adh Migr; 2024 Dec; 18(1):1-17. PubMed ID: 38555517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Infiltration Landscape in Lung Squamous Cell Carcinoma Implications.
    Zhao J; Bao W; Cai W
    Biomed Res Int; 2020; 2020():5981870. PubMed ID: 33102584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients.
    Zhang B; Tang B; Gao J; Li J; Kong L; Qin L
    J Transl Med; 2020 Sep; 18(1):342. PubMed ID: 32887635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hub genes and immune cell infiltration identified by bioinformatics analysis in pelvic organ prolapse.
    Zhao Y; Xia Z; Lin T; Yin Y
    PeerJ; 2020; 8():e9773. PubMed ID: 32874785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.
    Chang Z; Huang R; Fu W; Li J; Ji G; Huang J; Shi W; Yin H; Wang W; Meng T; Huang Z; Wei Q; Qin H
    Front Cell Dev Biol; 2020; 8():688. PubMed ID: 32850813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma.
    Zhou X; Qiu S; Jin D; Jin K; Zheng X; Yang L; Wei Q
    Front Genet; 2020; 11():569884. PubMed ID: 33240321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy.
    Liu J; Liu Q; Zhang X; Cui M; Li T; Zhang Y; Liao Q
    Cancer Cell Int; 2021 Feb; 21(1):137. PubMed ID: 33637086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
    Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
    Front Immunol; 2020; 11():560074. PubMed ID: 33304345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major Histocompatibility Complex Genes as Therapeutic Opportunity for Immune Cold Molecular Cancer Subtypes.
    Karpiński P; Łaczmański Ł; Sąsiadek MM
    J Immunol Res; 2020; 2020():8758090. PubMed ID: 33282963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer.
    Wang S; Xiong Y; Zhang Q; Su D; Yu C; Cao Y; Pan Y; Lu Q; Zuo Y; Yang L
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33302293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
    Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.